Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Resistant Hypertension
NCT02743390Phase 4Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Mar 2015
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in resistant hypertension (RH), sponsored by Universidade Estadual de Campinas. Started Mar 2015; status: completed.
02
Drugs
infliximab
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02743390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743390.